340B Drug Pricing Program
The AHA, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, and Children’s Hospital Association yesterday urged the U.S. Courts of Appeals for the 3rd and District of Columbia Circuits to require drug companies to fulfill their legal obligations to provide 340B…
The Health Resources and Services Administration late last week told Merck that it must immediately begin offering its covered outpatient drugs at the 340B ceiling price to covered entities through their contract pharmacy arrangements, regardless of whether they purchase through an in-house…
Reminder: Deadline is April 29 to Submit Information to AHA.
We recently sent you a note asking for your help completing a form that will help with our advocacy efforts to push back against illegal actions several drug manufacturers are taking to limit 340B pricing to contract pharmacies. Thank you to those organizations that already have completed the form.
President Biden today submitted to Congress his budget request for fiscal year (FY) 2023.
AHA shares proposals to lower Medicare drug prices with congress.
The Senate last night passed a $1.5 trillion omnibus appropriations bill that would fund the federal government through the end of the current fiscal year.
The House of Representatives last night passed a $1.5 trillion omnibus appropriations bill that would fund the federal government through the end of the current fiscal year. The legislation also includes provisions beneficial to hospitals and health systems.
The House Appropriations Committee announced an agreement on omnibus appropriations legislation funding the federal government through the end of the current fiscal year.
AHA urges HHS to ensure hospitals participating in the 340B Drug Pricing Program do not lose access to the program as a result of changes in patterns of patient care due to the COVID-19 public health emergency (PHE).